At the time of writing, GoodRx Holdings Inc [GDRX] stock is trading at $4.84, down -0.41%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GDRX shares have gain 12.82% over the last week, with a monthly amount drifted -24.14%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
GoodRx Holdings Inc [NASDAQ: GDRX] stock has seen the most recent analyst activity on August 09, 2024, when Raymond James upgraded its rating to a Strong Buy but kept the price target unchanged to $10 for it. Previously, RBC Capital Mkts upgraded its rating to Outperform on May 23, 2024, and elevated its price target to $10. On May 16, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $10 on the stock. KeyBanc Capital Markets upgraded its rating to a Overweight but stick to its price target of $9 on April 10, 2024. Wells Fargo upgraded its rating to a Overweight and raised its price target to $10 on March 25, 2024. JP Morgan upgraded its rating to Overweight for this stock on March 01, 2024, and upped its price target to $10. In a note dated February 26, 2024, Leerink Partners initiated an Outperform rating and provided a target price of $8 on this stock.
For the past year, the stock price of GoodRx Holdings Inc fluctuated between $4.09 and $9.26. Currently, Wall Street analysts expect the stock to reach $14.57 within the next 12 months. GoodRx Holdings Inc [NASDAQ: GDRX] shares were valued at $4.84 at the most recent close of the market. An investor can expect a potential return of 201.03% based on the average GDRX price forecast.
Analyzing the GDRX fundamentals
According to GoodRx Holdings Inc [NASDAQ:GDRX], the company’s sales were 790.38M for trailing twelve months, which represents an 8.50% jump. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.78 points at the first support level, and at 4.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.91, and for the 2nd resistance point, it is at 4.98.
Ratios To Look Out For
It is important to note that GoodRx Holdings Inc [NASDAQ:GDRX] has a current ratio of 5.48. In addition, the Quick Ratio stands at 5.48 and the Cash Ratio stands at 3.71. Considering the valuation of this stock, the price to sales ratio is 2.32, the price to book ratio is 2.65.
Transactions by insiders
Recent insider trading involved Spectrum Equity VII, L.P., 10% Owner, that happened on Sep 03 ’24 when 10677.0 shares were sold. Affiliate, Spectrum VII Investment Manage completed a deal on Sep 03 ’24 to buy 6828.0 shares. Meanwhile, Affiliate Spectrum VII Co-Investment Fun bought 3849.0 shares on Sep 03 ’24.
